Lixte Biotechnology Holdings Inc - Company Profile

Powered by

All the data and insights you need on Lixte Biotechnology Holdings Inc in one report.

  • Save hours of research time and resources with
    our up-to-date Lixte Biotechnology Holdings Inc Strategy Report

  • Understand Lixte Biotechnology Holdings Inc position in the market,
    performance and strategic initiatives.

  • Gain competitive edge and increase your
    chances of success

Back to companies

Lixte Biotechnology Holdings Inc: Executives

The following section provides information on Lixte Biotechnology Holdings Inc’s senior management, executives, CEO and key decision makers and their roles in the organization. For more insight into Lixte Biotechnology Holdings Inc's management and employees, unlock the full data with our company analytics monitoring tool.

Executives

John S. Kovach, M.D.

Chief Scientific Officer; Chairman Executive Board Since: 2023

Dr. John S. Kovach has been the Chairman of the company since September 2023. He serves as a Chief Scientific Officer and the Director of the company since 2005. Previously he served as a Chief Executive Officer of the company. Prior to this, he served at the City of Hope National Medical Center as the Executive Vice President for medical and scientific affairs from 1994 to 2000. Mr. Kovach also served as a Consultant in oncology and a Director of the Cancer Pharmacology Division of the Mayo Clinic from 1976 to 1994. He was also the Chair of the Department of Oncology and the Director of the NCI-designated Mayo Comprehensive Cancer Center from 1986 to 1994.

Read Hide full bio of John S. Kovach, M.D.

Bas van der Baan

Chief Executive Officer; President; Vice Chairman Executive Board Since: 2023

Mr. Bas van der Baan has been the President and Chief Executive Officer and Vice Chairman of the company since September 2023. Prior to this, he served as a Chief Clinical and Business Development Officer of Agendia, Inc.

Read Hide full bio of Bas van der Baan

Robert N. Weingarten

Vice President; Chief Financial Officer Senior Management Since: 2020 Age: 70

Mr. Robert N. Weingarten has been the Vice President and the Chief Financial Officer of the company since 2020. Prior to this, he served as the Director of Guardion Health Sciences Inc. Before that Mr. Weingarten served as the Chief Financial Officer of Alltemp Inc.

Read Hide full bio of Robert N. Weingarten

Eric J. Forman

Vice President; Chief Operating Officer Senior Management Since: 2022 Age: 42

Mr. Eric J. Forman has been the Chief Operating Officer and Vice President of the company since 2022. Prior to this, he served as the Chief Administrative Officer and Head of Business Development of the company. Previously, he served as the Counsel and Senior Project Manager at Shore Group Associates.

Read Hide full bio of Eric J. Forman

James Miser

Chief Medical Officer Senior Management Since: 2020 Age: 75

Mr. James Miser has been the Chief Medical Officer of the company since July 2020. Prior to this role, he served as the President, Chief Executive Officer and Chief Medical Officer at Seattle Children’s Hospital and City of Hope National Medical Center.

Read Hide full bio of James Miser
Gain a 360-degree view of Lixte Biotechnology Holdings Inc and make more informed decisions for your business Gain a 360-degree view of Lixte Biotechnology Holdings Inc and make more informed decisions for your business Find out more
Still looking?

Have you found what you were looking for? From start-ups to market leaders, uncover what they do and how they do it.

Explorer

Access more premium companies when you subscribe to Explorer

Start of HubSpot Embed Code End of HubSpot Embed Code